• Rapid Dose Therapeutics delivered a QuickStrip production line to Callan JMB for installation at its cGMP facility in Texas.
• The shipment advances a collaboration outlined on November 13, 2025, aimed at establishing US production of oral thin-film drugs.
• Production has not begun; operations remain subject to definitive agreements, equipment qualification and regulatory requirements.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Dose Therapeutics Corp. published the original content used to generate this news brief via pressetext (Ref. ID: 202610221004PRESSTXTEUPR__DE2C272B139C32CD1727377849949FABE) on October 22, 2026, and is solely responsible for the information contained therein.